Hongwei Gao
- Immunology top 1%
- Immune Response and Inflammation 37
-
- Traditional Chinese Medicine Analysis 14
- Pharmacology top 1%
- Cancer Research top 5%
- NF-κB Signaling Pathways 16
- Molecular Biology top 5%
- Natural product bioactivities and synthesis 17
- Inflammasome and immune disorders 12
- Cell death mechanisms and regulation 10
-
- Cytokine Signaling Pathways and Interactions 14
-
- Sepsis Diagnosis and Treatment 9
- Co-authors
- Peter A. WardShilin YangJ. Vidya SarmaRenyikun YuanChunguang YanFiras S. ZetouneThomas A. NeffMin Wu
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Hongwei Gao
141 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 1.9k
- Complementary and alternative medicine 344
- Pharmacology 349
- Cancer Research 564
- Molecular Biology 2.5k
Countries citing papers authored by Hongwei Gao
This map shows the geographic impact of Hongwei Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Gao more than expected).
Fields of papers citing papers by Hongwei Gao
This network shows the impact of papers produced by Hongwei Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Gao. The network helps show where Hongwei Gao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongwei Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 19 | |
| 9 | 2022 | 53 | |
| 10 | 2021 | 21 | |
| 11 | Fe-Curcumin Nanozyme-Mediated Reactive Oxygen Species Scavenging and Anti-Inflammation for Acute Lung Injurybreakdown → | 2021 | 202 |
| 12 | 2020 | 32 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 101 | |
| 16 | 2020 | 28 | |
| 17 | 2019 | 71 | |
| 18 | 2019 | 16 | |
| 19 | 2019 | 112 | |
| 20 | 2018 | 71 |
About Hongwei Gao
Hongwei Gao is a scholar working on Immunology, Complementary and alternative medicine and Toxicology, having authored 147 papers that have together received 5.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (37 papers), Natural product bioactivities and synthesis (17 papers), NF-κB Signaling Pathways (16 papers), Cytokine Signaling Pathways and Interactions (14 papers), Traditional Chinese Medicine Analysis (14 papers), Inflammasome and immune disorders (12 papers), Cell death mechanisms and regulation (10 papers) and Sepsis Diagnosis and Treatment (9 papers). The work is most often cited by research in Immunology (1.9k citations), Complementary and alternative medicine (344 citations) and Pharmacology (349 citations). Hongwei Gao has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Peter A. Ward, Shilin Yang, J. Vidya Sarma, Renyikun Yuan, Chunguang Yan, Firas S. Zetoune, Thomas A. Neff, Min Wu, Cecilia L. Speyer and Shan Han.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.